Breast Surgery & Reconstruction Centers
Surgical programs specializing in breast augmentation, reduction, lift, and post-mastectomy reconstruction including implant-based and autologous tissue reconstruction.
Market snapshot
These figures describe Plastic & Reconstructive Surgery (4.10.21), the segment that Breast Surgery & Reconstruction Centers sits within — not Breast Surgery & Reconstruction Centers on its own.
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so plastic surgery is not separately sized.
Business model & economics
Revenue model
Cash-pay cosmetic plus reconstructive reimbursement
Key economics
- Recurring revenue
- Low
- EBITDA margin
- 20–30% on cash-pay cosmetic
- Capex intensity
- Moderate
procedure- and occasion-driven
Characteristics
- Cosmetic side largely cash-pay and discretionary.
- Aesthetics-boom demand growth.
- Consolidation alongside med-spa platforms.
M&A deal context
Who’s acquiring
- Aesthetics & med-spa platforms
- PE-backed consolidators
- Multispecialty acquirers
What’s driving deals
- Medical-aesthetics-driven demand.
- Consolidation with med-spa platforms.
- Discretionary-spending sensitivity.
Find Breast Surgery & Reconstruction Centers acquisition targets
Search Acquisera’s index for companies classified under Breast Surgery & Reconstruction Centers (4.10.21.2) and build a targeted deal pipeline.
Search companies